PL2760848T3 - Sposoby otrzymywania kabazytakselu powiązane z sililowaniem c(7)-oh i c(13)-oh lub z sililowaniem tylko c(7)-oh - Google Patents

Sposoby otrzymywania kabazytakselu powiązane z sililowaniem c(7)-oh i c(13)-oh lub z sililowaniem tylko c(7)-oh

Info

Publication number
PL2760848T3
PL2760848T3 PL12783667T PL12783667T PL2760848T3 PL 2760848 T3 PL2760848 T3 PL 2760848T3 PL 12783667 T PL12783667 T PL 12783667T PL 12783667 T PL12783667 T PL 12783667T PL 2760848 T3 PL2760848 T3 PL 2760848T3
Authority
PL
Poland
Prior art keywords
silylation
cabazitaxel
involving
processes
preparation
Prior art date
Application number
PL12783667T
Other languages
English (en)
Inventor
Saswata Lahiri
Nitin Gupta
Abul AZIM
Nilendu Panda
Bhuwan Bhaskar MISHRA
Sunil Sanghani
Original Assignee
Fresenius Kabi Oncology Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Oncology Limited filed Critical Fresenius Kabi Oncology Limited
Publication of PL2760848T3 publication Critical patent/PL2760848T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
PL12783667T 2011-09-26 2012-09-21 Sposoby otrzymywania kabazytakselu powiązane z sililowaniem c(7)-oh i c(13)-oh lub z sililowaniem tylko c(7)-oh PL2760848T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2794DE2011 2011-09-26
EP12783667.4A EP2760848B1 (en) 2011-09-26 2012-09-21 Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
PCT/IN2012/000630 WO2013069027A1 (en) 2011-09-26 2012-09-21 Processes for the preparation of cabazitaxel involving c(7) -oh and c(13) -oh silylation or just c(7) -oh silylation

Publications (1)

Publication Number Publication Date
PL2760848T3 true PL2760848T3 (pl) 2019-07-31

Family

ID=47146459

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12783667T PL2760848T3 (pl) 2011-09-26 2012-09-21 Sposoby otrzymywania kabazytakselu powiązane z sililowaniem c(7)-oh i c(13)-oh lub z sililowaniem tylko c(7)-oh

Country Status (6)

Country Link
US (2) US8901327B2 (pl)
EP (1) EP2760848B1 (pl)
CN (1) CN104039771B (pl)
ES (1) ES2712804T3 (pl)
PL (1) PL2760848T3 (pl)
WO (1) WO2013069027A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2688877B1 (en) 2011-04-12 2017-03-08 Teva Pharmaceuticals International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US20130090484A1 (en) * 2011-10-11 2013-04-11 Scinopharm Taiwan Ltd. Process for making an intermediate of cabazitaxel
KR101407353B1 (ko) * 2012-12-04 2014-06-17 주식회사 삼양바이오팜 10-디아세틸바카틴 iii으로부터 카바지탁셀을 고수율로 제조하는 새로운 방법 및 이를 위한 신규 중간체
CN106632158B (zh) * 2013-08-28 2018-11-06 江苏恒瑞医药股份有限公司 7β,10β-二甲氧基-10-去乙酰基浆果赤霉素III的制备方法
CN103664837B (zh) * 2013-08-30 2016-01-20 北京阳光诺和药物研究有限公司 一种高纯度卡巴他赛中间体的制备方法
CN104292188A (zh) * 2014-08-21 2015-01-21 四川汇宇制药有限公司 一种卡巴他赛的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399726A (en) 1993-01-29 1995-03-21 Florida State University Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
FR2696462B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
FR2696459B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5453521A (en) 1992-10-05 1995-09-26 Rhone-Poulenc Rorer S.A. Process for obtaining 10-deacetylbaccatin III
FR2696463B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US5847170A (en) 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6372780B2 (en) * 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6124482A (en) 1998-07-27 2000-09-26 Dabur Research Foundation Process for isolation of 10-deacetyl baccatin-III
US6410757B1 (en) 1999-02-16 2002-06-25 Bio Research Corporation Of Yokohama Baccatin derivatives and a process for producing the same
WO2005113528A1 (en) 2004-05-14 2005-12-01 Immunogen, Inc. A facile method for synthesizing baccatin iii compounds
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
US8791279B2 (en) * 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
WO2012088391A1 (en) * 2010-12-22 2012-06-28 Nektar Therapeutics Non-ring hydroxy substituted taxanes and methods for synthesizing the same
EP2688877B1 (en) * 2011-04-12 2017-03-08 Teva Pharmaceuticals International GmbH Solid state forms of cabazitaxel and processes for preparation thereof

Also Published As

Publication number Publication date
WO2013069027A1 (en) 2013-05-16
US9000193B2 (en) 2015-04-07
CN104039771B (zh) 2017-10-27
EP2760848A1 (en) 2014-08-06
ES2712804T3 (es) 2019-05-14
US20140058119A1 (en) 2014-02-27
US8901327B2 (en) 2014-12-02
CN104039771A (zh) 2014-09-10
US20150057454A1 (en) 2015-02-26
WO2013069027A9 (en) 2013-10-17
EP2760848B1 (en) 2018-11-28

Similar Documents

Publication Publication Date Title
IL266582A (en) Preparations and methods for the treatment of hemoglobin diseases
HK1199099A1 (en) Methods and compositions for the treatment and diagnosis of cancer
EP2675469A4 (en) COMPOSITIONS, DEVICES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCER
EP2736528A4 (en) COMPOSITIONS AND METHODS OF TREATING HIV
IL225471A0 (en) Preparations and methods for the prevention and treatment of cancer
EP2552433A4 (en) COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES
SI2627334T1 (sl) Sestavki za uporabo pri zdravljenju virusnih infekcij
EP2688594A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
ZA201303375B (en) Tailings stream treatment processes
IL238177A0 (en) Methods and preparations for the treatment of cancer
EP2723924A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER
PL2760848T3 (pl) Sposoby otrzymywania kabazytakselu powiązane z sililowaniem c(7)-oh i c(13)-oh lub z sililowaniem tylko c(7)-oh
EP2696874A4 (en) COMPOSITIONS AND METHODS USED TO TREAT NASAL CONDITIONS
EP2558085A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER
EP2753363A4 (en) MG53 COMPOSITIONS AND METHOD FOR THE TREATMENT AND PREVENTION OF RESPIRATORY INFLUENZES
GB201001412D0 (en) Propolis and process for the treatment thereof
EP2635273A4 (en) ISOFLAVONOID COMPOSITIONS AND METHOD FOR CANCER TREATMENT
HK1213891A1 (zh) 製備伏立康唑及其類似物的方法
EP2661434A4 (en) NEW URGES FOR THE TREATMENT AND PREVENTION OF CANCER
EP2547368A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
ZA201302639B (en) Antibodies for the treatment of hiv
EP3603631C0 (en) METHODS AND COMPOSITIONS FOR TREATING DIVERTICULOSIS
AP3540A (en) Process for the preparation of anagrelide and analogues thereof
EP2861586A4 (en) FORMS OF VILAZODONE AND METHODS OF PREPARATION THEREOF